Open-label Extension Study in Participants With Early Alzheimer's Disease

NCT07105709 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: GSK4527226

Sponsor

GlaxoSmithKline

Collaborators

[object Object]